Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway

Abstract Background Resistance can develop during treatment of advanced endometrial cancer (EC), leading to unsatisfactory results. Fanconi anemia complementation group D2 (Fancd2) has been shown to be closely related to drug resistance in cancer cells. Therefore, this study was designed to explore...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Hai-Hong Lin, Wei-Hong Zeng, Hai-Kun Yang, Li-Shan Huang, Ru Pan, Nan-Xiang Lei
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2024-01-01
Rangatū:	BMC Women's Health
Ngā marau:	Fancd2 Endometrial cancer Chemotherapeutic agents Drug resistance Ferroptosis
Urunga tuihono:	https://doi.org/10.1186/s12905-023-02857-4
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!